Neurogene NGNE

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

• SCHEDULE 13GOct. 7, 2026, 11:07 a.m. ETView on SEC.gov
• SCHEDULE 13GOct. 6, 2026, 1:49 p.m. ETView on SEC.gov
• 4Oct. 2, 2026, 2:49 p.m. ETView on SEC.gov
• SCHEDULE 13G/AAug. 14, 2026, 4:15 p.m. ETView on SEC.gov
• SCHEDULE 13GAug. 14, 2026, 6:05 a.m. ETView on SEC.gov
• SCHEDULE 13G/AAug. 14, 2026, 4:16 p.m. ETView on SEC.gov
• 10-QAug. 11, 2026, 4:57 p.m. ETView on SEC.gov
• 8-KAug. 11, 2026, 7:32 a.m. ETView on SEC.gov

  Results of operations and financial condition · Financial statements and exhibits